
ADC Therapeutics enters licence option deal with Avacta Group
Under the terms of the agreement, Avacta Group (Cambridge, UK) will provide three small Affimer proteins designed to bind to undisclosed cancer...

New method allows tracking of HIV
According to study leaders Prof. Christian Eggeling from Leibniz IPHT, Dr. Cyril Favard and Dr. Delphine Muriaux from the Montpellier Infectious...

Qiagen/Illumina: Earthquake in NGS IVD market
The announcement of the 15-year partnership of next generation sequencing (NGS) market leader Illumina and QIAGEN came after Illumina cut its 2019...

Gut bacterial enzyme keeps inflammation away
In studies in human cells, Victor Duarte and colleagues from University of Grenoble, found broad-spectrum antimicrobial activity of a compound...

Test detects breast cancer in earliest stage
The new research results were presented at the 2019 NCRI Cancer Conference today by Daniyah Alfattani from National Cancer Research Institute (NCRI)...

Tecentriq-Avastin combo hits endpoint in liver cancer
Data from 501 treatment-native HCC patients enrolled in the open label IMbrave150 Phase III study demonstrated a incremental improvement...

Tacalyx GmbH raises €7m in seed funding
The financing was co-led by Boehringer Ingelheim Venture Fund and Kurma Partners. Idinvest Partners, High-Tech Gründerfonds (HTGF), coparion,...